vs
TechnipFMC plc（FTI）与SELECT MEDICAL HOLDINGS CORP（SEM）财务数据对比。点击上方公司名可切换其他公司
TechnipFMC plc的季度营收约是SELECT MEDICAL HOLDINGS CORP的1.8倍（$2.5B vs $1.4B），TechnipFMC plc净利率更高（9.6% vs 1.4%，领先8.2%），SELECT MEDICAL HOLDINGS CORP同比增速更快（6.4% vs 6.3%），TechnipFMC plc自由现金流更多（$359.1M vs $5.2M），过去两年TechnipFMC plc的营收复合增速更高（11.0% vs 2.8%）
TechnipFMC是一家注册地位于英国的全球能源服务商，兼具法国与美国企业背景，核心业务为油气领域提供专业技术与服务支持。公司由美国FMC科技与法国Technip于2016年宣布合并，2017年正式完成组建，业务覆盖全球主要能源市场。
Select Medical是总部位于美国宾夕法尼亚州的医疗健康企业，业务涵盖长期急症护理、住院康复医院运营，同时开设有职业健康与物理治疗诊所，母公司Select Medical Holdings在纽约证券交易所挂牌上市。
FTI vs SEM — 直观对比
营收规模更大
FTI
是对方的1.8倍
$1.4B
营收增速更快
SEM
高出0.1%
6.3%
净利率更高
FTI
高出8.2%
1.4%
自由现金流更多
FTI
多$353.9M
$5.2M
两年增速更快
FTI
近两年复合增速
2.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.5B | $1.4B |
| 净利润 | $242.7M | $20.2M |
| 毛利率 | — | — |
| 营业利润率 | 12.6% | 4.6% |
| 净利率 | 9.6% | 1.4% |
| 营收同比 | 6.3% | 6.4% |
| 净利润同比 | 8.0% | 225.7% |
| 每股收益（稀释后） | $0.58 | $0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FTISEM
| Q4 25 | $2.5B | $1.4B | ||
| Q3 25 | $2.6B | $1.4B | ||
| Q2 25 | $2.5B | $1.3B | ||
| Q1 25 | $2.2B | $1.4B | ||
| Q4 24 | $2.4B | $1.3B | ||
| Q3 24 | $2.3B | $1.3B | ||
| Q2 24 | $2.3B | $1.3B | ||
| Q1 24 | $2.0B | $1.3B |
净利润FTISEM
| Q4 25 | $242.7M | $20.2M | ||
| Q3 25 | $309.7M | $28.8M | ||
| Q2 25 | $269.5M | $40.6M | ||
| Q1 25 | $142.0M | $56.7M | ||
| Q4 24 | $224.7M | $-16.1M | ||
| Q3 24 | $274.6M | $55.6M | ||
| Q2 24 | $186.5M | $77.6M | ||
| Q1 24 | $157.1M | $96.9M |
毛利率FTISEM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 23.1% | — | ||
| Q1 25 | 20.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 21.2% | — | ||
| Q1 24 | 16.4% | — |
营业利润率FTISEM
| Q4 25 | 12.6% | 4.6% | ||
| Q3 25 | 16.5% | 5.4% | ||
| Q2 25 | 15.9% | 6.5% | ||
| Q1 25 | 12.5% | 8.3% | ||
| Q4 24 | 11.3% | 1.6% | ||
| Q3 24 | 13.7% | 4.3% | ||
| Q2 24 | 13.3% | 5.8% | ||
| Q1 24 | 12.7% | 9.0% |
净利率FTISEM
| Q4 25 | 9.6% | 1.4% | ||
| Q3 25 | 11.7% | 2.1% | ||
| Q2 25 | 10.6% | 3.0% | ||
| Q1 25 | 6.4% | 4.2% | ||
| Q4 24 | 9.5% | -1.2% | ||
| Q3 24 | 11.7% | 4.4% | ||
| Q2 24 | 8.0% | 6.1% | ||
| Q1 24 | 7.7% | 7.3% |
每股收益（稀释后）FTISEM
| Q4 25 | $0.58 | $0.17 | ||
| Q3 25 | $0.75 | $0.23 | ||
| Q2 25 | $0.64 | $0.32 | ||
| Q1 25 | $0.33 | $0.44 | ||
| Q4 24 | $0.51 | $-0.12 | ||
| Q3 24 | $0.63 | $0.43 | ||
| Q2 24 | $0.42 | $0.60 | ||
| Q1 24 | $0.35 | $0.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $26.5M |
| 总债务越低越好 | $430.0M | $1.8B |
| 股东权益账面价值 | $3.4B | $1.7B |
| 总资产 | $10.1B | $5.9B |
| 负债/权益比越低杠杆越低 | 0.13× | 1.06× |
8季度趋势，按日历期对齐
现金及短期投资FTISEM
| Q4 25 | $1.0B | $26.5M | ||
| Q3 25 | $876.6M | $60.1M | ||
| Q2 25 | $950.0M | $52.3M | ||
| Q1 25 | $1.2B | $53.2M | ||
| Q4 24 | $1.2B | $59.7M | ||
| Q3 24 | — | $191.5M | ||
| Q2 24 | — | $111.2M | ||
| Q1 24 | — | $92.6M |
总债务FTISEM
| Q4 25 | $430.0M | $1.8B | ||
| Q3 25 | $438.0M | $1.7B | ||
| Q2 25 | $696.3M | $1.8B | ||
| Q1 25 | $904.9M | $1.8B | ||
| Q4 24 | $885.2M | $1.7B | ||
| Q3 24 | $966.7M | $3.1B | ||
| Q2 24 | $968.4M | $3.6B | ||
| Q1 24 | $1.0B | $3.8B |
股东权益FTISEM
| Q4 25 | $3.4B | $1.7B | ||
| Q3 25 | $3.3B | $1.7B | ||
| Q2 25 | $3.3B | $1.7B | ||
| Q1 25 | $3.1B | $1.7B | ||
| Q4 24 | $3.1B | $1.7B | ||
| Q3 24 | $3.3B | $1.9B | ||
| Q2 24 | $3.0B | $1.4B | ||
| Q1 24 | $3.0B | $1.4B |
总资产FTISEM
| Q4 25 | $10.1B | $5.9B | ||
| Q3 25 | $10.3B | $5.7B | ||
| Q2 25 | $10.1B | $5.7B | ||
| Q1 25 | $10.0B | $5.7B | ||
| Q4 24 | $9.9B | $5.6B | ||
| Q3 24 | $9.7B | $8.0B | ||
| Q2 24 | $9.2B | $7.9B | ||
| Q1 24 | $9.1B | $7.9B |
负债/权益比FTISEM
| Q4 25 | 0.13× | 1.06× | ||
| Q3 25 | 0.13× | 1.03× | ||
| Q2 25 | 0.21× | 1.10× | ||
| Q1 25 | 0.29× | 1.03× | ||
| Q4 24 | 0.29× | 1.01× | ||
| Q3 24 | 0.30× | 1.62× | ||
| Q2 24 | 0.33× | 2.54× | ||
| Q1 24 | 0.34× | 2.75× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $453.6M | $64.3M |
| 自由现金流经营现金流 - 资本支出 | $359.1M | $5.2M |
| 自由现金流率自由现金流/营收 | 14.3% | 0.4% |
| 资本支出强度资本支出/营收 | 3.8% | 4.2% |
| 现金转化率经营现金流/净利润 | 1.87× | 3.19× |
| 过去12个月自由现金流最近4个季度 | $1.4B | $117.2M |
8季度趋势，按日历期对齐
经营现金流FTISEM
| Q4 25 | $453.6M | $64.3M | ||
| Q3 25 | $525.1M | $175.3M | ||
| Q2 25 | $344.2M | $110.3M | ||
| Q1 25 | $441.7M | $-3.5M | ||
| Q4 24 | $578.9M | $125.4M | ||
| Q3 24 | $277.9M | $181.0M | ||
| Q2 24 | $230.9M | $278.2M | ||
| Q1 24 | $-126.7M | $-66.7M |
自由现金流FTISEM
| Q4 25 | $359.1M | $5.2M | ||
| Q3 25 | $447.8M | $122.2M | ||
| Q2 25 | $260.6M | $45.6M | ||
| Q1 25 | $379.9M | $-55.8M | ||
| Q4 24 | $452.7M | $62.0M | ||
| Q3 24 | $225.3M | $130.3M | ||
| Q2 24 | $180.1M | $222.6M | ||
| Q1 24 | $-178.7M | $-119.2M |
自由现金流率FTISEM
| Q4 25 | 14.3% | 0.4% | ||
| Q3 25 | 16.9% | 9.0% | ||
| Q2 25 | 10.3% | 3.4% | ||
| Q1 25 | 17.0% | -4.1% | ||
| Q4 24 | 19.1% | 4.7% | ||
| Q3 24 | 9.6% | 10.2% | ||
| Q2 24 | 7.7% | 17.4% | ||
| Q1 24 | -8.8% | -9.0% |
资本支出强度FTISEM
| Q4 25 | 3.8% | 4.2% | ||
| Q3 25 | 2.9% | 3.9% | ||
| Q2 25 | 3.3% | 4.8% | ||
| Q1 25 | 2.8% | 3.9% | ||
| Q4 24 | 5.3% | 4.8% | ||
| Q3 24 | 2.2% | 4.0% | ||
| Q2 24 | 2.2% | 4.3% | ||
| Q1 24 | 2.5% | 4.0% |
现金转化率FTISEM
| Q4 25 | 1.87× | 3.19× | ||
| Q3 25 | 1.70× | 6.09× | ||
| Q2 25 | 1.28× | 2.72× | ||
| Q1 25 | 3.11× | -0.06× | ||
| Q4 24 | 2.58× | — | ||
| Q3 24 | 1.01× | 3.25× | ||
| Q2 24 | 1.24× | 3.59× | ||
| Q1 24 | -0.81× | -0.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FTI
| Services | $1.3B | 52% |
| Products | $1.1B | 44% |
| Other | $55.1M | 2% |
| Surface Technologies | $22.4M | 1% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
